Julie Rubinstein Adaptive Biotechnologies Corp (ADPT) insider trading activity

ADPT Quotes by TradingView

Julie Rubinstein is President of Adaptive Biotechnologies Corp. Currently has a direct ownership of 472,754 shares of ADPT, which is worth approximately $2.51 Million. The most recent transaction as insider was on Jan 28, 2021, when has been sold 15,000 shares (Common Stock) at a price of $6.32 per share, resulting in proceeds of $94,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 473K
0% 3M change
40.36% 12M change
Total Value Held $2.51 Million

JULIE RUBINSTEIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 28 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 27 2021
SELL
Open market or private sale
$887,700 $59.18 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 27 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 26 2021
SELL
Open market or private sale
$977,550 $65.17 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 26 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 25 2021
SELL
Open market or private sale
$996,900 $66.46 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 25 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 22 2021
SELL
Open market or private sale
$1,000,650 $66.71 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 22 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 21 2021
SELL
Open market or private sale
$1,003,200 $66.88 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 21 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 20 2021
SELL
Open market or private sale
$1,012,050 $67.47 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 20 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 19 2021
SELL
Open market or private sale
$1,050,000 $70.0 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 19 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 15 2021
SELL
Open market or private sale
$995,700 $66.38 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 14 2021
SELL
Open market or private sale
$988,800 $65.92 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 14 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 13 2021
SELL
Open market or private sale
$948,900 $63.26 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 13 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 12 2021
SELL
Open market or private sale
$941,850 $62.79 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 12 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 11 2021
SELL
Open market or private sale
$910,200 $60.68 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 11 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
JR

Julie Rubinstein

President
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADPT